Oncology drug development company Celsion recently spoke about its recent development in the way of helping those with brain cancer. Specifically, the company would focus on glioblastoma, which is commonly regarded in this field of research. It's not hard to see why, as this particular tumor has been considered the most serious and aggressive form of tumor in the brain. Can a new approach by this company, though, prove to be helpful for not only patients who are afflicted but the entire scope of research seen here?
It seems like there is the possibility for this to happen, as an article on Pharmaceutical Business Review detailed. With a certain approach brought into effect, the goal is to help treat tumors in the brain, with glioblastoma being the primary focus. While it's clear that this ailment has been given focus by organizations such as Voices against Brain Cancer, one has to wonder what exactly this approach entails. There are a couple of elements that can help to bring this approach together and allow it to be successful.
The company will put together experiments that will determine how effective ThermoDox is when put together with MR guided high intensity focused ultrasound. While the focus will be set on animal subjects first, it can possibly come into effect to help humans if results are great. Dr. Nicholas Borys said that Thermodox would be able to help give patients great clinical benefit, seeing as how it is a, "heat-activated liposomal encapsulation of doxorubicin." The fact that it has been used to help other forms of cancer, liver included, is worthy of note.
The report spoke about a phase III HEAT study that has been done in order to test the effective of ThermoDox in addition to RFA. The study was conducted in order to see how well patients would react to this particular combination. From what I have gathered by the results, ThermoDox could actually work well in order to improve PFS, provided that that the lesions of patients undergo RFA for around 45 minutes. As it stands, positive results are to be seen in this regard.
Who is it to say that these results couldn't come into play for future results, either? I have to believe that there is more with the ThermoDox approach than what has been seen already; why else would it have such a great deal of focus placed on it? With its usage in other types of cancer, it seems as though potential results can be found in the way of brain cancer as well. It's just a matter of making sure that the best strategies are seen and carried out.
It seems like there is the possibility for this to happen, as an article on Pharmaceutical Business Review detailed. With a certain approach brought into effect, the goal is to help treat tumors in the brain, with glioblastoma being the primary focus. While it's clear that this ailment has been given focus by organizations such as Voices against Brain Cancer, one has to wonder what exactly this approach entails. There are a couple of elements that can help to bring this approach together and allow it to be successful.
The company will put together experiments that will determine how effective ThermoDox is when put together with MR guided high intensity focused ultrasound. While the focus will be set on animal subjects first, it can possibly come into effect to help humans if results are great. Dr. Nicholas Borys said that Thermodox would be able to help give patients great clinical benefit, seeing as how it is a, "heat-activated liposomal encapsulation of doxorubicin." The fact that it has been used to help other forms of cancer, liver included, is worthy of note.
The report spoke about a phase III HEAT study that has been done in order to test the effective of ThermoDox in addition to RFA. The study was conducted in order to see how well patients would react to this particular combination. From what I have gathered by the results, ThermoDox could actually work well in order to improve PFS, provided that that the lesions of patients undergo RFA for around 45 minutes. As it stands, positive results are to be seen in this regard.
Who is it to say that these results couldn't come into play for future results, either? I have to believe that there is more with the ThermoDox approach than what has been seen already; why else would it have such a great deal of focus placed on it? With its usage in other types of cancer, it seems as though potential results can be found in the way of brain cancer as well. It's just a matter of making sure that the best strategies are seen and carried out.
About the Author:
If you'd care for more information regarding glioblastoma, please consult Voices against Brain Cancer.
Aucun commentaire:
Enregistrer un commentaire